Imbruvica FDA Approved Drugs
IMBRUVICA [IbrutinibC25H24N6O2]
RX
- 140mg (oral capsule)
Pharmacyclics IncNov 13, 2013
- For the treatment of patients with waldenstrom's macroglobulinemia.
- Treatment for chronic lymphocytic leukemia with 17p deletion.
- Treatment of chronic lymphocytic leukemia.
- Treatment of mantle cell lymphoma.
- Treatment of marginal zone lymphoma.
- Treatment of small lymphocytic lymphoma.
- Treatment of waldenstrom's macroglobulinemia.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.